EA201500218A1 - Антрахинондиоксимы и их применение - Google Patents

Антрахинондиоксимы и их применение

Info

Publication number
EA201500218A1
EA201500218A1 EA201500218A EA201500218A EA201500218A1 EA 201500218 A1 EA201500218 A1 EA 201500218A1 EA 201500218 A EA201500218 A EA 201500218A EA 201500218 A EA201500218 A EA 201500218A EA 201500218 A1 EA201500218 A1 EA 201500218A1
Authority
EA
Eurasian Patent Office
Prior art keywords
anthrainedioxymes
application
derivatives
compounds
cancer
Prior art date
Application number
EA201500218A
Other languages
English (en)
Other versions
EA030302B1 (ru
Inventor
Веслав М. Холодий
И Цзан
Карина Зук
Джеффри В.Х. Уоттхи
Зое Охлер
Джеффри Стровел
Норман Е. Охлер
Шила Челлаппан
Джанак Падия
Original Assignee
Форест Лэборетериз Холдингз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Форест Лэборетериз Холдингз Лимитед filed Critical Форест Лэборетериз Холдингз Лимитед
Publication of EA201500218A1 publication Critical patent/EA201500218A1/ru
Publication of EA030302B1 publication Critical patent/EA030302B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В изобретении раскрыты антрахинондиоксимы и их производные для применения в лечении заболеваний, в частности рака, например рака толстой кишки и колоректального рака. Кроме того, в изобретении представлены способы синтеза упомянутых производных. Также описаны композиции этих соединений и метаболиты указанных соединений, а также их применение в модулировании генов.
EA201500218A 2008-11-21 2008-11-21 Антрахинондиоксимы и их применение EA030302B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/012995 WO2010059142A1 (en) 2008-11-21 2008-11-21 Anthraquinone dioximes and uses thereof

Publications (2)

Publication Number Publication Date
EA201500218A1 true EA201500218A1 (ru) 2015-09-30
EA030302B1 EA030302B1 (ru) 2018-07-31

Family

ID=42198382

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201500218A EA030302B1 (ru) 2008-11-21 2008-11-21 Антрахинондиоксимы и их применение
EA201270376A EA022290B1 (ru) 2008-11-21 2008-11-21 Антрахинондиоксимы и их применение

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201270376A EA022290B1 (ru) 2008-11-21 2008-11-21 Антрахинондиоксимы и их применение

Country Status (2)

Country Link
EA (2) EA030302B1 (ru)
WO (1) WO2010059142A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013067547A1 (en) * 2011-11-06 2013-05-10 Beta Cat Pharmaceuticals, Llc METHODS FOR TREATMENT OF DISEASES AND DISORDERS RELATED TO TRANSDUCIN β-LIKE PROTEIN 1 (TBL 1) ACTIVITY, INCLUDING MYELOPROLIFERATIVE NEOPLASIA AND CHRONIC MYELOID LEUKEMIA
TW201718495A (zh) 2015-07-28 2017-06-01 貝塔貓製藥股份有限公司 蒽-9, 10-二酮二肟化合物前驅藥及其用途
WO2017058716A1 (en) * 2015-09-28 2017-04-06 Vivace Therapeutics, Inc. Tricyclic compounds
CN105837478B (zh) * 2016-04-20 2017-11-14 成都理工大学 作为p2x3和p2x2/3受体拮抗剂的双磺酰基蒽二酮双肟衍生物
EP3630101A4 (en) 2017-06-02 2021-01-20 Iterion Therapeutics, Inc. DISEASE TREATMENT METHODS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627791A (en) * 1968-11-21 1971-12-14 Richardson Merrell Inc Bis(aminoalkylsulfamoyl) anthraquinones
GB2025954A (en) * 1978-07-21 1980-01-30 Ciba Geigy Ag Anthraquinone Sulphonamides
GB2166453B (en) * 1984-08-01 1987-10-28 Ciba Geigy Ag Purification process
AU2003232785A1 (en) * 2002-07-17 2004-02-02 Zentaris Gmbh Novel anthracene derivatives and the use thereof as a medicament
US6693136B1 (en) * 2002-07-26 2004-02-17 Abbott Laboratories Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors
US6949557B2 (en) * 2003-04-29 2005-09-27 Dabur Research Foundation Hydroanthracene based compounds as anticancer agents

Also Published As

Publication number Publication date
EA201270376A1 (ru) 2012-12-28
WO2010059142A1 (en) 2010-05-27
EA022290B1 (ru) 2015-12-30
EA030302B1 (ru) 2018-07-31

Similar Documents

Publication Publication Date Title
EA200870569A1 (ru) Соединения и способы модуляции fxr
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
RU2448096C3 (ru) Диарилгидантоины
EA201101650A1 (ru) Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний
EA201070148A1 (ru) Соединения и способы модулирования фарнезоидного рецептора x (fxr)
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
EA200801362A1 (ru) Пиримидинил бензотиофеновые соединения
EA201000016A1 (ru) Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
EA200801041A1 (ru) Ингибиторы мек и способы их применения
EA200870116A1 (ru) Бициклические гетероарильные соединения
NO20073788L (no) Kjemiske forbindelser
EA201070247A1 (ru) Ингибиторы протеасом
UA107783C2 (en) Isoindoline compounds for use in treating cancer
MA32508B1 (fr) Composes organiques
EA201490132A1 (ru) Противовирусные соединения
EA201101182A1 (ru) Новые аминоазагетероциклические карбоксамиды
EA201100299A1 (ru) Органические соединения
EA201290727A1 (ru) Пирролбензодиазепины и их конъюгаты
DK1853602T3 (da) Kemiske forbindelser
EA201000550A1 (ru) Производные тиазола
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA201300610A1 (ru) Хиназолинкарбоксамидазетидины

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM